Medicine and Healthcare | Media Room | Newswire

Regentis Biomaterials to Present at the 2026 ThinkEquity Conference on October 15 in New York City

Fri, 09 Oct 2026 20:05:00 +0000

RGNT to present at ThinkEquity Conference Oct. 15, 2026 in New York. Learn about GelrinC knee cartilage implant and one-on-one investor meetings

Vogenx Appoints Board Member Richard Gorman as Chief Commercial Officer

Fri, 09 Oct 2026 12:00:00 +0000

Thirty-year biopharmaceutical commercial leader transitions from the Board of Directors to Chief Commercial Officer

Appointment strengthens corporate strategy, business development and commercial readiness as the Company advances mizagliflozin following its August 2026 initial public offering

Surmodics Launches IOL Cartridge Coating Automation Center in Horsham

Wed, 07 Oct 2026 19:30:00 +0000

New center combines advanced hydrophilic coating technology, IOL cartridge application expertise and automated processing to support scalable ophthalmic device manufacturing

Vituity Cares Brings Music and Purpose to Nashville With Benefit Concert at Cannery Hall

Wed, 07 Oct 2026 13:00:00 +0000

Demola, Elijah Scott, Coey Redd, DJ Delano, Trew the Star, and Jeffrey ‘Sax' Stevenson come together for a special evening of live music supporting Vituity Cares' mission to expand access to care and strengthen communities

Napo Pharmaceuticals, a Jaguar Health Family Company, Sponsoring Intestinal Failure Panel Discussion at Pediatric Gastroenterology Conference in Abu Dhabi

Tue, 06 Oct 2026 13:00:00 +0000

Company remains sharply focused on its ongoing rare disease intestinal failure global development program for microvillus inclusion disease (MVID) and short bowel syndrome (SBS) for crofelemer powder for oral solution, targeting an NDA filing for MVID mid-2027

A recent Rareatives article shares the story of a young child living with MVID, highlighting the importance of family perspectives, supportive communication, and collaboration with clinicians in addressing rare intestinal diseases

Bluejay Diagnostics Announces SYMON-II Clinical Dataset Details Supporting Evaluation of Mortality Risk in Sepsis and Septic Shock

Tue, 06 Oct 2026 10:30:00 +0000

SYMON-II Clinical Validation Dataset Represents a Key Milestone as Bluejay Advances the Symphony™ IL-6 Test Toward Regulatory Submission

The Assistance Fund Opens New Program for Glycogen Storage Disorder Type 1A

Mon, 05 Oct 2026 16:00:00 +0000

Financial Assistance From The Assistance Fund Now Available for Eligible People Living With Glycogen Storage Disorder Type 1A

The Assistance Fund Opens New Program for MPS IIIA-Sanfilippo A Syndrome

Mon, 05 Oct 2026 16:00:00 +0000

Financial Assistance From The Assistance Fund Now Available for Eligible People Living With MPS IIIA-Sanfilippo A Syndrome

NanoViricides Provides Additional Details on the Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola as the Outbreak Continues to Expand and Has Taken Over 4,000 Lives

Mon, 05 Oct 2026 12:45:00 +0000

Jaguar Health Announces a Special Stock Dividend

Sat, 03 Oct 2026 00:35:00 +0000

Dividend intended to provide dilution protection to Jaguar shareholders as company continues evaluation of strategic alternatives

California Care Recovery Launches Quarterly Scholarship Covering Full Cost of Addiction Treatment - Including Travel - at No Cost

Thu, 01 Oct 2026 16:00:00 +0000

The Care Forward Scholarship awards up to $60,000 in treatment every quarter to one person in need, at no cost

Surmodics Acquires Alta Biomed Business, Expanding Hemocompatible Surface Technology and Analytical Testing Capabilities

Thu, 01 Oct 2026 12:00:00 +0000

Acquisition adds proven PzF^™ thin-film surface modification technology, specialized blood- and tissue-contacting device expertise and a West Coast testing facility

MD Clarity Unveils Major Expansion of RevFind with Agentic AI to Optimize the Revenue of Provider Organizations

Wed, 30 Sep 2026 15:00:00 +0000

MD Clarity expands RevFind product’s agentic AI capabilities to detect underpayments and denials, uncover root causes, and prioritize recovery opportunities

Chicken Soup for the Soul Co-Author Publishes Ayahuasca For the Soul

Tue, 29 Sep 2026 17:10:00 +0000

79 true stories of hope, healing and breakthrough from veterans, celebrities, CEOs and everyday seekers who journeyed with plant medicine

NanoViricides, Inc. Has Filed its Annual Report: Broad-spectrum Antiviral NV-387 Is In Phase II Clinical Trials

Tue, 29 Sep 2026 12:45:00 +0000

Preliminary Results of Open-Label Study in Adult Short Bowel Syndrome Patients with Intestinal Failure (SBS-IF) with Jaguar Health's Crofelemer Accepted for Presentation at Annual American College of Gastroenterology Meeting

Tue, 29 Sep 2026 08:30:00 +0000

Company remains sharply focused on its ongoing rare disease intestinal failure global development program for microvillus inclusion disease (MVID) and SBS-IF for crofelemer powder for oral solution, targeting an NDA filing for MVID mid-2027

Clinical Trial of the Oral Drug NV-387 to Treat Ebola Has Started Enrollment and Dosing of Patients Last Week (on or about September 23rd), Says NanoViricides

Mon, 28 Sep 2026 12:45:00 +0000

Innovasis Receives FDA Clearance for Nano-Scale Surface Designation on AxTiHA, TxTiHA, and HAtetracell-C Implants

Fri, 25 Sep 2026 18:20:00 +0000

Engineered 20-nanometer surface architecture on Innovasis' HA-coated titanium implants was reviewed and cleared under the FDA's Nanotechnology Guidance, confirming nanoscale surface features with increased hydrophilicity compared to micro-rough titanium surfaces.

NGD Infection Prevention Announces Launch of Transmission Detection at Sheba Medical Center in Israel

Thu, 24 Sep 2026 22:15:00 +0000

NGD's automated whole genome sequencing and bioinformatic result generation is accelerating Sheba's ability to detect the spread of drug-resistant bacterial infection

Wellness Recovery Center Opens New Residential Eating Disorder Treatment Center in Orange County

Thu, 24 Sep 2026 19:00:00 +0000

The Tustin Ranch-area facility offers 24/7 inpatient care in a residential setting for adults 18 and older living with eating disorders and co-occurring mental health conditions

As Microdosing Culture Grows, Sacred Connection Introduces Amazonian Grounding Botanicals to Solve Modern "Heady" Burnout

Thu, 24 Sep 2026 13:00:00 +0000

Addressing the growing demand for non-psychedelic micro-rituals, Sacred Connection bridges ancestral Amazonian preparations with North America's microdosing and flow-state communities.

Power Couple Dr. Vinson Eugene Allen and Dr. Connie Yu Allen Honored by the Los Angeles Business Journal

Wed, 23 Sep 2026 20:40:00 +0000

Healthcare leaders recognized for advancing accessible care and strengthening community health programs

NGD Infection Prevention Announces Launch of Transmission Detection at Sheba Medical Center in Israel

Wed, 23 Sep 2026 19:50:00 +0000

NGD's automated whole genome sequencing and bioinformatic result generation is accelerating Sheba's ability to detect the spread of drug-resistant bacterial infection

Phase II Clinical Trial of NV-387 as a Treatment for Monkeypox (MPox) Has Begun in DRC, Announces NanoViricides

Wed, 23 Sep 2026 12:30:00 +0000

Introducing Missouri Valley Regional Medical Center: A New Name for a New Chapter in Community Healthcare

Wed, 23 Sep 2026 11:00:00 +0000

Fitzgibbon Hospital Adopts New Identity Reflecting Its Commitment to Serving Marshall and Communities Throughout the Region

ACU-Serve and Tennr Partner to Transform Front-End Operations for Post-Acute Care Providers

Tue, 22 Sep 2026 18:00:00 +0000

Partnership combines Tennr's patient orchestration technology with ACU-Serve's revenue cycle expertise to help providers scale, improve intake efficiency and move patients to care faster.

Sacred Connection Launches Ancestral Pre-Meditation Ritual to Eliminate Cognitive Friction and Accelerate Stillness

Tue, 22 Sep 2026 14:30:00 +0000

Bridging ancient Amazonian botanicals with modern mindfulness practices, Sacred Connection offers a fast-acting grounding tool to quiet internal noise before meditation sits.

Jaguar Health Receives Fee Waivers from FDA

Tue, 22 Sep 2026 13:05:00 +0000

Company remains sharply focused on its ongoing rare disease intestinal failure global development program for microvillus inclusion disease (MVID) and SBS for crofelemer powder for oral solution, targeting an NDA filing for MVID mid-2027

Vogenx Appoints Ken Toombs to Board of Directors

Tue, 22 Sep 2026 13:00:00 +0000

Former Chief Executive Officer of PA Consulting brings three decades of global professional services and life sciences leadership experience

Appointment broadens independent oversight as the Company scales operations following its August 2026 initial public offering

MCS Accelerates Catheter Manufacturing with QuickShip PTFE Glass Mandrels

Tue, 22 Sep 2026 13:00:00 +0000

MCS has recently expanded its Quick Ship Program product line to include over 500 different sizes of precision-ground mandrels in stock and ready to ship the next business day.

Mountain Land Physical Therapy ("Mountain Land") Partners with OccuPro to Expand Employer-Focused Rehab Services

Thu, 17 Sep 2026 15:40:00 +0000

Partnership strengthens workers' compensation physical therapy, industrial rehabilitation, FCE, and return-to-work programs across Utah, Idaho, and Montana

Infinx Earns No. 1 Ranking for Provider-Side Prior Authorization Automation and PAIR Readiness

Thu, 17 Sep 2026 14:20:00 +0000

Black Book Research's 2026 hospital RCM rankings place Infinx first in a client-rated category focused on prior authorization automation

Sacred Connection Introduces Ancestral Amazonian Protocol for Chronic Sinus Pressure and Tension Headaches

Thu, 17 Sep 2026 14:00:00 +0000

Offering a natural, plant-based alternative to chemical decongestants and pain relievers, Sacred Connection brings direct-trade botanical preparations to those seeking rapid head and sinus relief.

American Medical Administrators, Inc. Appoints Mark D. Goldberg, MD, as Chief Medical Officer

Wed, 16 Sep 2026 12:00:00 +0000

Veteran Physician Leader to Advance Clinical Strategy, Physician Engagement and Value-Based Care Initiatives

Sacred Connection Partners with Non-Profit Conexão Ancestral to Fight Botanical Exploitation and Fund Vital Amazonian Indigenous Projects

Tue, 15 Sep 2026 14:00:00 +0000

Combining radical supply-chain transparency with direct non-profit action, Sacred Connection funds clean water infrastructure, cultural preservation, and land stewardship across Huni Kuin, Yawanawá, and Katukina villages.

Clinical Trial of the Oral Drug NV-387 to Treat Ebola to Start Next Week, Hoping to Reduce Fatalities and Spread, As the Largest Ebola Outbreak is Expanding in  DR Congo with 48% Crude Fatality Rate, Says NanoViricides

Tue, 15 Sep 2026 13:25:00 +0000

Jaguar Health, Inc. Announces Reverse Stock Split

Tue, 15 Sep 2026 13:00:00 +0000

Reverse split approved at April 2026 Special Meeting of Stockholders

Shares of Jaguar Health common stock to begin trading on split-adjusted basis on September 17, 2026

Lobe Sciences to Present Low-Dose L-130 Clinical Data at 9th Neuropsychiatric Drug Development Summit

Tue, 15 Sep 2026 03:00:00 +0000

● Dr. Frederick D. Sancilio to present "Reimagining Psychedelic Therapeutics for Daily Outpatient Use: Advancing Low-Dose Psilocin Beyond the Hallucinogenic Paradigm" on Wednesday, September 16

● Presentation covers Phase 1a first-in-human results for Conjugated Psilocin™ (L-130), including oral bioavailability, dose consistency and the absence of hallucinogenic effects at low doses

● Lobe to exhibit throughout the summit, September 15-17, alongside senior discovery, clinical and business development leaders from major pharmaceutical companies

Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update

Fri, 11 Sep 2026 13:00:00 +0000

Advances GelrinC^® U.S. pivotal trial with 43 patients treated; Completion of enrollment expected by approximately year end 2026

Expands European commercialization readiness, including surgeon training and regulatory approval of new manufacturing process that improves production yield 400%

Strengthened balance sheet with $6.5 million private placement in June 2026

Ahead of 9/11, U.S. Veterans' Non-Profit Partners with World's Only Medically Licensed Ayahuasca Facility to Combat PTSD and Suicide

Thu, 10 Sep 2026 17:27:00 +0000

This private, veteran-only retreat will offer medically supervised plant medicine treatment and long-term integration support for veterans living with treatment-resistant PTSD

Sacred Connection Launches Direct-Trade Amazonian Grounding Botanicals in the U.S. to Combat Modern Digital Burnout

Thu, 10 Sep 2026 14:00:00 +0000

Bridging ancestral Amazonian wisdom with modern somatic wellness, Sacred Connection introduces ethically sourced Hapé blends designed to reset overstimulated minds in 60 seconds.

Surmodics Opens Medical Device Coating Capabilities in Ireland

Thu, 10 Sep 2026 14:00:00 +0000

The Galway Facility Brings Nearly 50 Years of Coating Expertise, Cleanroom Coating Services and Analytical Testing Closer to Medical Device Manufacturers Across Ireland and Europe

The Longevity Centers of America Opens Central Florida Location in Orlando's Dr. Phillips Corridor

Thu, 10 Sep 2026 14:00:00 +0000

The physician-led longevity and regenerative medicine practice is opening its first clinic in the Orlando area and is now accepting patients for the waitlist ahead of its September 28 opening.

All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)

Thu, 10 Sep 2026 13:00:00 +0000

Continuation of treatment with blinded doses of crofelemer in the extension phase of the trial will support company's plans to file an NDA in mid-2027 for MVID, an ultrarare pediatric disease

Transition of Fitzgibbon Hospital Operations Complete; American Medical Administrators Begins Management of Hospital and Related Healthcare Operations

Wed, 09 Sep 2026 22:55:00 +0000

Hospital, Skilled Nursing Facility and Rural Health Clinics Remain Open and Continue Serving the Community

Alpha Genesis Launches AGI Ventures with an Initial $50 Million Commitment to Emerging Biotechnology Companies

Wed, 09 Sep 2026 13:00:00 +0000

New venture-development division pairs strategic investment with the scientific expertise and preclinical research infrastructure of Alpha Genesis

Sacred Connection Unveils Ancestral Flow-State Priming Tool for the Biohacking and Performance Community

Tue, 08 Sep 2026 14:00:00 +0000

Designed for precision state control and rapid vagal activation, Sacred Connection brings direct-trade Amazonian botanical preparations to peak-performance protocols.

Now Available on Amazon: Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in Dogs

Tue, 08 Sep 2026 13:00:00 +0000

Neonorm^® Dog extends Jaguar's existing Neonorm product franchise beyond foals and calves to provide dog owners with access to a plant-based product designed to support normal stool consistency and GI fluid balance in dogs

Jaguar expects Neonorm Dog to be available through other select online and animal health retail channels shortly, including Chewy

Clinical Trial for an Oral Drug to Treat Ebola is Registered in the Pan African Clinical Trials Database and is Ready to Go, As the Largest Ebola Outbreak Continues to Expand in DR Congo

Tue, 08 Sep 2026 12:30:00 +0000

On Labor Day, Guardian Angel AI Turns Attention to America's $1 Trillion Unpaid Workforce: Family Caregivers

Mon, 07 Sep 2026 09:00:00 +0000

As millions of Americans spend the holiday caring for aging parents and loved ones, Guardian Angel AI is building technology designed to make aging at home safer - and caregiving less consuming.

Medicine and Healthcare | Media Room | Newswire

Regentis Biomaterials to Present at the 2026 ThinkEquity Conference on October 15 in New York City

Vogenx Appoints Board Member Richard Gorman as Chief Commercial Officer

Surmodics Launches IOL Cartridge Coating Automation Center in Horsham

Vituity Cares Brings Music and Purpose to Nashville With Benefit Concert at Cannery Hall

Napo Pharmaceuticals, a Jaguar Health Family Company, Sponsoring Intestinal Failure Panel Discussion at Pediatric Gastroenterology Conference in Abu Dhabi

Bluejay Diagnostics Announces SYMON-II Clinical Dataset Details Supporting Evaluation of Mortality Risk in Sepsis and Septic Shock

The Assistance Fund Opens New Program for Glycogen Storage Disorder Type 1A

The Assistance Fund Opens New Program for MPS IIIA-Sanfilippo A Syndrome

NanoViricides Provides Additional Details on the Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola as the Outbreak Continues to Expand and Has Taken Over 4,000 Lives

Jaguar Health Announces a Special Stock Dividend

California Care Recovery Launches Quarterly Scholarship Covering Full Cost of Addiction Treatment - Including Travel - at No Cost

Surmodics Acquires Alta Biomed Business, Expanding Hemocompatible Surface Technology and Analytical Testing Capabilities

MD Clarity Unveils Major Expansion of RevFind with Agentic AI to Optimize the Revenue of Provider Organizations

Chicken Soup for the Soul Co-Author Publishes Ayahuasca For the Soul

NanoViricides, Inc. Has Filed its Annual Report: Broad-spectrum Antiviral NV-387 Is In Phase II Clinical Trials

Preliminary Results of Open-Label Study in Adult Short Bowel Syndrome Patients with Intestinal Failure (SBS-IF) with Jaguar Health's Crofelemer Accepted for Presentation at Annual American College of Gastroenterology Meeting

Clinical Trial of the Oral Drug NV-387 to Treat Ebola Has Started Enrollment and Dosing of Patients Last Week (on or about September 23rd), Says NanoViricides

Innovasis Receives FDA Clearance for Nano-Scale Surface Designation on AxTiHA, TxTiHA, and HAtetracell-C Implants

NGD Infection Prevention Announces Launch of Transmission Detection at Sheba Medical Center in Israel

Wellness Recovery Center Opens New Residential Eating Disorder Treatment Center in Orange County

As Microdosing Culture Grows, Sacred Connection Introduces Amazonian Grounding Botanicals to Solve Modern "Heady" Burnout

Power Couple Dr. Vinson Eugene Allen and Dr. Connie Yu Allen Honored by the Los Angeles Business Journal

NGD Infection Prevention Announces Launch of Transmission Detection at Sheba Medical Center in Israel

Phase II Clinical Trial of NV-387 as a Treatment for Monkeypox (MPox) Has Begun in DRC, Announces NanoViricides

Introducing Missouri Valley Regional Medical Center: A New Name for a New Chapter in Community Healthcare

ACU-Serve and Tennr Partner to Transform Front-End Operations for Post-Acute Care Providers

Sacred Connection Launches Ancestral Pre-Meditation Ritual to Eliminate Cognitive Friction and Accelerate Stillness

Jaguar Health Receives Fee Waivers from FDA

Vogenx Appoints Ken Toombs to Board of Directors

MCS Accelerates Catheter Manufacturing with QuickShip PTFE Glass Mandrels

Mountain Land Physical Therapy ("Mountain Land") Partners with OccuPro to Expand Employer-Focused Rehab Services

Infinx Earns No. 1 Ranking for Provider-Side Prior Authorization Automation and PAIR Readiness

Sacred Connection Introduces Ancestral Amazonian Protocol for Chronic Sinus Pressure and Tension Headaches

American Medical Administrators, Inc. Appoints Mark D. Goldberg, MD, as Chief Medical Officer

Sacred Connection Partners with Non-Profit Conexão Ancestral to Fight Botanical Exploitation and Fund Vital Amazonian Indigenous Projects

Clinical Trial of the Oral Drug NV-387 to Treat Ebola to Start Next Week, Hoping to Reduce Fatalities and Spread, As the Largest Ebola Outbreak is Expanding in DR Congo with 48% Crude Fatality Rate, Says NanoViricides

Jaguar Health, Inc. Announces Reverse Stock Split

Lobe Sciences to Present Low-Dose L-130 Clinical Data at 9th Neuropsychiatric Drug Development Summit

Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update

Ahead of 9/11, U.S. Veterans' Non-Profit Partners with World's Only Medically Licensed Ayahuasca Facility to Combat PTSD and Suicide

Sacred Connection Launches Direct-Trade Amazonian Grounding Botanicals in the U.S. to Combat Modern Digital Burnout

Surmodics Opens Medical Device Coating Capabilities in Ireland

The Longevity Centers of America Opens Central Florida Location in Orlando's Dr. Phillips Corridor

All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)

Transition of Fitzgibbon Hospital Operations Complete; American Medical Administrators Begins Management of Hospital and Related Healthcare Operations

Alpha Genesis Launches AGI Ventures with an Initial $50 Million Commitment to Emerging Biotechnology Companies

Sacred Connection Unveils Ancestral Flow-State Priming Tool for the Biohacking and Performance Community

Now Available on Amazon: Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in Dogs

Clinical Trial for an Oral Drug to Treat Ebola is Registered in the Pan African Clinical Trials Database and is Ready to Go, As the Largest Ebola Outbreak Continues to Expand in DR Congo

On Labor Day, Guardian Angel AI Turns Attention to America's $1 Trillion Unpaid Workforce: Family Caregivers

Clinical Trial of the Oral Drug NV-387 to Treat Ebola to Start Next Week, Hoping to Reduce Fatalities and Spread, As the Largest Ebola Outbreak is Expanding in  DR Congo with 48% Crude Fatality Rate, Says NanoViricides